IMDX Insight Molecular Diagnostics, Inc.: Prakiraan wutah bathi kanggo taun ngarep
Insight Molecular Diagnostics (IMDX) has implemented data processing automation and targeted robotics on its production lines. The trajectory of forward-looking EPS estimates reflects current dynamics, where 4.70 represents the current level of the metric. Looking ahead, the business relies on stable demand regardless of economic conditions, although it faces fierce competition for the recognition of new diagnostic methodologies within the medical community.
IMDX (Insight Molecular Diagnostics Inc): rincian analitis lan laporan miturut indikator
- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
- indikator kapitalisasi buku:
- data utang lan likuiditas:
Total Utang marang Modal Insight Molecular Diagnostics|IMDX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Insight Molecular Diagnostics, Inc.|IMDX - Tanggungan utang total perusahaan|Utang-utang marang kapitalisasi buku Insight Molecular Diagnostics|IMDX - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Insight Molecular Diagnostics|Indikator likuiditas cepet imdxinc.com
- data bathi resik lan rasio valuasi:
IMDX - Bathi pungkasan|Bathi sing dikarepake Insight Molecular Diagnostics|IMDX - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep Insight Molecular Diagnostics, Inc.|IMDX - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Insight Molecular Diagnostics|IMDX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Insight Molecular Diagnostics|IMDX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan imdxinc.com|IMDX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Insight Molecular Diagnostics
Analisis kabeh metrik perusahaan:Insight Molecular Diagnostics, IMDX
Rising demand for Insight Molecular Diagnostics (IMDX) automated molecular diagnostic systems directly determines the consensus valuation of net profit growth rates. This indicator measures the expected change in earnings per share (EPS) for the coming year, where the current value of 4.70 reflects the aggregate forecast of leading US analysts. Positive momentum on this chart confirms the scalability of the business, although a high degree of conservative valuation may restrain short-term explosive capital growth.
Analisis pesaing Insight Molecular Diagnostics
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|Quest Corp (DGX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep exactsciences.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Revvity RVTY|BIO: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|NNNN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Nordion SHC|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPK - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|CDNA (CareDx, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|MRVI - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep FLGT|LAB (Standard BioTools Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Cytek Biosciences, Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep OSUR (orasure.com)|XGN: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep MDXH (MDxHealth S.A.)|Lucid Diagnostics Inc (LUCD) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Prenetics|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Trinity Biotech PLC|Prakiraan wutah bathi resik saben saham ing taun ngarep prophaselabs.com PRPH|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Ainos (AIMD)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CODX (Co-Diagnostics Inc)|Prakiraan wutah bathi kanggo taun ngarep HSCS (Heart Test Laboratories Inc.)|Biomerica Inc (BMRA) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Cardio Diagnostics Holdings, Inc. - Prakiraan wutah bathi kanggo taun ngarep|onconetix.gcs-web.com (ONCO) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VRAX (Virax Biolabs) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Bluejay Diagnostics Inc (BJDX) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Vermillion|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AXDX|Prakiraan wutah bathi kanggo taun ngarep CNTG|Prakiraan wutah bathi kanggo taun ngarep enzo.com (ENZ)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fresh2 Group FRES|Dinamika bathi saben saham sing diarepake ing taun ngarep GENE|ME: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep PMD (Psychemedics Inc)
